CNBX Pharmaceuticals Inc. (CNBX)
USD 0.01
(42.86%)
USD 0.01
(42.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -112.52 Thousand | -1.67 Million | -2.49 Million | -2.77 Million | -3.09 Million | -1.97 Million |
| Net Income | -3.71 Million | -3.72 Million | -3.19 Million | -7.46 Million | 1.13 Million | -3.77 Million |
| Depreciation & Amortization | 162.06 Thousand | 198.52 Thousand | 220.92 Thousand | 215.15 Thousand | 188.92 Thousand | 88.44 Thousand |
| Deferred income taxes | - | -728.86 Thousand | -33.76 Thousand | -72.12 Thousand | -247.3 Thousand | - |
| Stock-based compensation | 180.48 Thousand | 728.86 Thousand | 33.76 Thousand | 72.12 Thousand | 247.3 Thousand | 1.92 Million |
| Change in working capital | 474.12 Thousand | 407.22 Thousand | -64.05 Thousand | 148.11 Thousand | -157.76 Thousand | -148.69 Thousand |
| Other non-cash items | 2.78 Million | 1.43 Million | 544.66 Thousand | 4.32 Million | -4.25 Million | 1.86 Million |
| Investing Cash Flow | 24.7 Thousand | 25.22 Thousand | 645.02 Thousand | 3.28 Million | -5.25 Million | -1.44 Million |
| Investments in PPE | 1.00 | -1656.00 | -943.00 | -75.74 Thousand | -216.88 Thousand | -942.39 Thousand |
| Acquisitions | - | 26.88 Thousand | - | - | 5.25 Million | - |
| Investment purchases | - | - | - | - | -5.03 Million | - |
| Sales/Maturities of investments | 24.7 Thousand | - | 645.96 Thousand | 3.36 Million | -1.92 Million | - |
| Other Investing Activities | 24.7 Thousand | 26.88 Thousand | 645.96 Thousand | 3.36 Million | 1.92 Million | -500 Thousand |
| Financing Cash Flow | 100 Thousand | 389.85 Thousand | 2.45 Million | - | 7.21 Million | 1.44 Million |
| Debt repayment | -100 Thousand | -389.85 Thousand | -2.45 Million | - | - | -22 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -76.98 Thousand | -85 Thousand |
| Common Stock Issuance | - | - | - | - | 7.29 Million | 1.55 Million |
| Other Financing Activities | 100 Thousand | 389.85 Thousand | 2.45 Million | - | -76.98 Thousand | -85 Thousand |
| Accounts receivables | -13.84 Thousand | 123.6 Thousand | -10.41 Thousand | 132.19 Thousand | -57.25 Thousand | -77.56 Thousand |
| Accounts payables | 487.96 Thousand | 283.62 Thousand | -53.63 Thousand | 15.91 Thousand | -100.5 Thousand | -71.13 Thousand |
| Inventory | - | - | 53.63 Thousand | -15.91 Thousand | - | -1.08 Million |
| Other working capital | -474.12 Thousand | - | -53.63 Thousand | 15.91 Thousand | - | 1.08 Million |
| Cash at beginning of period | 117.51 Thousand | 1.38 Million | 777.61 Thousand | 265.98 Thousand | 1.39 Million | 3.36 Million |
| Cash at end of period | 129.69 Thousand | 117.51 Thousand | 1.38 Million | 777.61 Thousand | 265.98 Thousand | 1.39 Million |
| Capital Expenditure | 1.00 | -1656.00 | -943.00 | -75.74 Thousand | -216.88 Thousand | -942.39 Thousand |
| Effect of forex changes on cash | - | -4853.00 | - | - | 1.00 | - |
| Net cash flow / Change in cash | 12.18 Thousand | -1.26 Million | 608.86 Thousand | 511.62 Thousand | -1.12 Million | -1.97 Million |
| Free Cash Flow | -112.52 Thousand | -1.68 Million | -2.49 Million | -2.85 Million | -3.31 Million | -2.91 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -130.63 Thousand | -325.45 Thousand | -178.52 Thousand | -3.71 Million | -573.55 Thousand | -154.69 Thousand |
| Depreciation & Amortization | - | 32.85 Thousand | 39.46 Thousand | 162.06 Thousand | 38.49 Thousand | 39.99 Thousand |
| Deferred income taxes | - | -34.97 Thousand | - | - | - | - |
| Stock-based compensation | 34.79 Thousand | 34.97 Thousand | 34.97 Thousand | 180.48 Thousand | 34.97 Thousand | 34.97 Thousand |
| Change in working capital | 130.83 Thousand | 4169.00 | 20.79 Thousand | 474.12 Thousand | 143.89 Thousand | 61.13 Thousand |
| Other non-cash items | -130.82 Thousand | 164.03 Thousand | 11.45 Thousand | 2.78 Million | 376.71 Thousand | -1.00 |
| Investing Cash Flow | 94.67 Thousand | 20 Thousand | -1196.00 | 24.7 Thousand | 24.7 Thousand | - |
| Investments in PPE | 5.00 | - | -1196.00 | - | - | - |
| Acquisitions | 94.67 Thousand | 20 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | -20 Thousand | - | - | 24.7 Thousand | - | - |
| Other Investing Activities | 94.67 Thousand | 20 Thousand | -1196.00 | 24.7 Thousand | 24.7 Thousand | - |
| Financing Cash Flow | 1259.00 | - | 24.99 Thousand | 100 Thousand | 65.02 Thousand | 14.99 Thousand |
| Debt repayment | -1259.00 | - | -24.99 Thousand | -100 Thousand | -65.02 Thousand | -14.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1259.00 | - | 24.99 Thousand | 100 Thousand | 130.05 Thousand | 14.99 Thousand |
| Accounts receivables | 120.15 Thousand | -57.48 Thousand | 25.32 Thousand | -13.84 Thousand | 210.03 Thousand | -243.55 Thousand |
| Accounts payables | 10.68 Thousand | 61.65 Thousand | -4533.00 | 487.96 Thousand | 352.18 Thousand | 304.68 Thousand |
| Inventory | - | - | - | - | -474.12 Thousand | -304.68 Thousand |
| Other working capital | -59.26 Thousand | - | - | -474.12 Thousand | 55.8 Thousand | 304.68 Thousand |
| Cash at beginning of period | 37.14 Thousand | 81.64 Thousand | 129.69 Thousand | 117.51 Thousand | 44.15 Thousand | 47.74 Thousand |
| Cash at end of period | 73.4 Thousand | 37.14 Thousand | 81.64 Thousand | 129.69 Thousand | 129.69 Thousand | 44.15 Thousand |
| Capital Expenditure | 5.00 | - | -1196.00 | - | - | - |
| Effect of forex changes on cash | -59.89 Thousand | 59.89 Thousand | - | - | -44.68 Thousand | - |
| Net cash flow / Change in cash | 36.26 Thousand | -44.5 Thousand | -48.04 Thousand | 12.18 Thousand | 85.54 Thousand | -3597.00 |
| Free Cash Flow | 230.00 | -124.39 Thousand | -73.04 Thousand | -112.52 Thousand | 20.51 Thousand | -18.59 Thousand |
WLAB
0I0H
328130
603708
JQ
5292